Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | +5.26% | -9.09% | -9.09% |
05-09 | Transcript : PYC Therapeutics Limited, Q2 2024 Earnings Call, May 09, 2024 | |
04-22 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 293M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Files IND Application with US FDA for Retinitis Pigmentosa Medication